I would not be surprised if we see a massive licen
Post# of 148175
I also would not be surprised if Merck and Pfizer are watching CytoDyn, licking their chops. Both Merck and Pfizer have put a lot of money into CCR5 research. Our drug is vastly superior to both of theirs, in a lot of ways.
Does anyone see either of them, making a play for CYDY?